JOHANNA PILLADO: Open Payments
NPI 1629686415 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$296 in 17 payments from 9 companies in 2025. Trend: 2023 $189 · 2024 $733 · 2025 $296
Food & beverage: $296
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $63 |
| Amgen Inc. | 3 | $50 |
| Alkermes, Inc. | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 2 | $29 |
| ABBVIE INC. | 2 | $28 |
| Exact Sciences Corporation | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Lundbeck LLC | 1 | $24 |
| Novo Nordisk Inc | 1 | $16 |
Products named: CAPLYTA, OTEZLA, VIVITROL, FANAPT, VRAYLAR, Cologuard Collection Kit, LEQVIO, REXULTI.
Industry payments across FL — which companies pay providers there.
